BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 12.439
AS - Asia 10.540
EU - Europa 5.543
SA - Sud America 1.400
AF - Africa 218
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 9
Totale 30.164
Nazione #
US - Stati Uniti d'America 12.109
SG - Singapore 3.747
VN - Vietnam 2.417
CN - Cina 1.842
HK - Hong Kong 1.174
BR - Brasile 1.071
RU - Federazione Russa 1.037
IT - Italia 1.004
DE - Germania 800
SE - Svezia 660
IE - Irlanda 413
GB - Regno Unito 364
UA - Ucraina 290
FR - Francia 273
IN - India 260
CA - Canada 194
FI - Finlandia 176
KR - Corea 152
BD - Bangladesh 142
TR - Turchia 129
AR - Argentina 128
ID - Indonesia 108
ES - Italia 92
IQ - Iraq 92
MX - Messico 86
AT - Austria 85
NL - Olanda 85
JP - Giappone 74
ZA - Sudafrica 67
PL - Polonia 56
PK - Pakistan 49
CO - Colombia 48
VE - Venezuela 45
PH - Filippine 44
SA - Arabia Saudita 43
UZ - Uzbekistan 42
EC - Ecuador 41
BE - Belgio 37
DK - Danimarca 31
EG - Egitto 31
LT - Lituania 28
MA - Marocco 23
CZ - Repubblica Ceca 22
MY - Malesia 22
CH - Svizzera 21
KE - Kenya 21
CL - Cile 20
TH - Thailandia 20
IR - Iran 19
JO - Giordania 16
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
TN - Tunisia 14
NP - Nepal 13
PE - Perù 13
AZ - Azerbaigian 12
ET - Etiopia 12
OM - Oman 12
UY - Uruguay 12
DZ - Algeria 11
IL - Israele 11
KG - Kirghizistan 11
LB - Libano 11
DO - Repubblica Dominicana 10
JM - Giamaica 10
SN - Senegal 10
CR - Costa Rica 8
HU - Ungheria 8
MN - Mongolia 8
AL - Albania 7
BG - Bulgaria 7
GR - Grecia 7
AU - Australia 6
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BO - Bolivia 5
PA - Panama 5
RO - Romania 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
CI - Costa d'Avorio 4
HR - Croazia 4
KH - Cambogia 4
LV - Lettonia 4
MD - Moldavia 4
TG - Togo 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
Totale 30.107
Città #
Singapore 1.839
Ann Arbor 1.382
Ashburn 1.300
Hong Kong 1.134
San Jose 948
Hanoi 689
Ho Chi Minh City 676
Chandler 644
Woodbridge 635
Fairfield 517
Houston 507
Frankfurt am Main 455
Dublin 402
Santa Clara 350
Los Angeles 346
New York 344
Dallas 339
Jacksonville 303
Wilmington 280
Hefei 271
Milan 262
Seattle 245
Beijing 244
The Dalles 218
Dearborn 214
Chicago 213
Cambridge 199
Princeton 173
Seoul 143
Hangzhou 123
Lauterbourg 122
Buffalo 116
Shanghai 115
São Paulo 109
Da Nang 101
Council Bluffs 90
Boardman 85
Moscow 85
Nanjing 78
Helsinki 76
Altamura 74
Jakarta 73
Orem 71
Munich 70
Lawrence 68
Haiphong 65
Nuremberg 62
Tokyo 61
Guangzhou 52
Montreal 52
Dong Ket 51
Lachine 51
London 50
Denver 49
San Diego 47
Vienna 45
Hải Dương 44
Warsaw 44
Biên Hòa 43
Toronto 42
Baghdad 41
Quận Bình Thạnh 37
Rome 36
Tashkent 36
Brussels 35
Can Tho 35
Rio de Janeiro 35
Shenyang 35
Brooklyn 34
Mountain View 34
Poplar 34
Thái Nguyên 34
Quận Một 33
Manchester 31
Atlanta 30
Johannesburg 30
Nanchang 30
Dhaka 29
Fremont 29
Stockholm 29
Phoenix 28
Hebei 27
Mexico City 27
Vũng Tàu 27
Andover 26
San Francisco 26
Turku 26
Amsterdam 25
Ninh Bình 25
Istanbul 24
Boston 23
Bắc Giang 23
Ha Long 22
Salt Lake City 22
Zhengzhou 22
Ankara 21
Changsha 21
Chennai 21
Madrid 21
Belo Horizonte 19
Totale 18.629
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.090
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 555
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 538
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 471
The role of clinical and neuroimaging features in the diagnosis of CADASIL 426
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 419
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 392
Guillain-Barré syndrome related to COVID-19 infection 380
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 379
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 376
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 372
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 368
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 360
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 354
Incidence and predictors of acute symptomatic seizures after stroke 353
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 350
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 348
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 343
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 338
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 332
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 324
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 312
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 308
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 305
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 305
Topographical and morphological patterns of post reperfusion molecular penumbra 303
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 302
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 296
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 293
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 290
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 289
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 284
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 283
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 279
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 278
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 277
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 275
Guillain–Barré Syndrome Associated with COVID-19 275
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 271
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 266
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 266
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 264
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 263
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 263
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 262
A multidisciplinary approach to screen the post-COVID-19 conditions 260
Thermal plantar test in experimental ischemic stroke 256
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 255
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 255
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 252
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 252
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 251
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 244
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 243
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 243
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 243
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 242
Cerebral collateral circulation in experimental ischemic stroke 239
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 234
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 233
The THRombolysis and STatins (THRaST) study 232
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 227
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 225
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 223
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 219
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 215
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 209
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 209
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 206
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 206
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 204
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 203
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 200
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 199
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 196
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 196
Pharmacological manipulation of glutamate transport 195
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 191
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 189
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 187
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 187
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 185
Brain ultrasound rehearsal before surgery: A pilot cadaver study 182
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 181
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 180
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 179
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 177
Spectral properties of the EEG during recovery of consciousness after acute brain injury 177
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 176
Elevated peripheral leukocyte counts in acute cervical artery dissection 175
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 175
Head down positioning before recanalization in acute ischemic stroke 172
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 170
Possible neuroprotective strategies in ALS 167
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 167
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 167
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 164
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients with COVID-19 Infected with Pre-Omicron Variants 160
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 159
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 152
Totale 26.962
Categoria #
all - tutte 92.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 0 80 159
2021/20221.378 129 137 155 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/202612.464 1.750 956 1.047 1.392 1.639 684 1.995 583 971 1.241 206 0
Totale 30.841